Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Corrigendum To The Intimation Submitted Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnel Dated 11Th March, 2024

With reference to our Intimation dated 11th March, 2024, submitted to the Exchange regarding appointment of Ms. Namita Patwari, Senior Management Personnel of the Company, we hereby submit this corrigendum to clarify that the Designation of Ms. Namita Patwari be read as Chief Human Resources Officer (CHRO) for India Branded Business .
15-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find attached herewith, intimation regarding Issue of Duplicate Share Certificate from our RTA.
13-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached herewith the Copy of the Newspaper Publication
13-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find attached herewith, intimation for issue of duplicate share certificate received from our RTA.
11-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Change in Management

Please find attached herewith the Intimation for Appointment of SMP
11-03-2024

Alembic Pharma drops 2% on USFDA 4 observations for Gujarat facility

The US drug regulator had inspected Alembic Pharma's oncology formulations (injectable and oral solid) unit at Panelav in Gujarat from February 28 to March 8
11-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - US FDA Inspection At Alembic Pharmaceuticals Limited'S Oncology (Injectable And Oral Solid) Formulation Facility At Panelav

The USFDA has conducted an inspection at our Oncology (injectable and Oral Solid) Formulation Facility at Panelav from 28th February, 2024 to 8th March, 2024. The USFDA issued a Form 483 with four procedural observation.
08-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find attached herewith, the intimation received from our RTA.
07-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Credit Rating

Please find attached herewith the Intimation regarding reaffirmation of Credit Rating for various Banking facilities of the Company received from CRISIL Ratings Limited vide its Letter dated 7th March, 2024.
07-03-2024
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find attached herewith, Stop Transfer intimation received from Link Intime India Pvt. Ltd.
05-03-2024
Next Page
Close

Let's Open Free Demat Account